Osteosarcopenic obesity in cardiovascular patients. Controversial and open issues by K. E. Krivoshapova, V. L. Masenko, E. D. Bazdyrev, O. L. Barbarash

“…T. in Opinion of invited editor, pp. 54-55.The study of osteosarcopenic obesity (OSO) in patients with cardiovascular diseases (CVDs) in recent years has caused a dis-cussion on common pathogenesis of atherosclerosis, obesity, progressive loss of skeletal and muscle mass. …”
Get full text

CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE by Ye. D. Bazdyrev, Ye. B. Gerasimova, O. M. Polikutina, I. A. Savelieva, S. A. Smakotina, O. L. Barbarash

“…The cardiovascular system was assessed with echocardiography and ambulatory blood pressure monitoring (ABPM).…”
Get full text

NUTRITION AS THE RISK FACTOR FOR CARDIOVASCULAR PATHOLOGY FROM EPIDEMIOLOGICAL PERSPECTIVE by D. P. Tsygankova, K. Е. Krivoshapova, O. L. Barbarash

“…Nutrition is a crucial element of patient management in cardiovascular disorders. Recently, a variety of diets considered, for prevention of obesity as for risk reduction of severe cardiovascular pathology. …”
Get full text

CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE by Ye. D. Bazdyrev, Ye. B. Gerasimova, O. M. Polikutina, I. A. Savelieva, S. A. Smakotina, O. L. Barbarash

“…Objective: to detect previously undiagnosed arterial hypertension in patients with chronic obstructive pulmonary disease (COPD) as a risk factor for cardiovascular mortality.Materials and methods. 43 patients with stage I–II of COPD and the absence of clinical signs of cardiovascular diseases were examined. …”
Get full text

CYTOKINE PROFILE IN VISCERAL OBESITY AND ADVERSE CARDIOVASCULAR PROGNOSIS OF MYOCARDIAL INFARCTION by O. V. Gruzdeva, O. E. Akbasheva, V. G. Matveeva, Yu. A. Dyleva, E. I. Palicheva, V. N. Karetnikova, D. A. Borodkina, A. N. Kokov, T. S. Fedorova, O. L. Barbarash

“…Over the year, adverse cardiovascular events proved to be more frequent in patients with visceral obesity. …”
Get full text

The role of immune cells in the development of adipose tissue dysfunction in cardiovascular diseases by E. G. Uchasova, O. V. Gruzdeva, Yu. A. Dyleva, E. V. Belik, O. L. Barbarash

Subjects: Get full text

Association of smoking with coronary artery disease depending on other cardiovascular risk factors by E. D. Bazdyrev, S. A. Maksimov, N. A. Galimova, T. A. Mulerova, E. V. Indukaeva, G. V. Artamonova, O. L. Barbarash

“…We analyzed the results of the multicenter epidemiological study “Epidemiology of cardiovascular diseases and their risk factors in the Russian Federation” in Kemerovo region obtained from a random sample of 1,599 subjects aged 25–64 years. …”
Get full text

Changes in Cardiovascular Risk Factors in Residents of the Siberian Region (According to Epidemiological Studies) by G. V. Artamonova, S. A. Maksimov, D. P. Tsygankova, E. D. Bazdyrev, E. V. Indukaeva, T. A. Mulerova, E. B. Shapovalova, A. S. Agienko, O. V. Nakhratova, O. L. Barbarash

Subjects: “…cardiovascular risk…”
Get full text

CHANGES OF CARDIOVASCULAR STABILITY IN CORONARY PATIENTS AND HEALTHY CONTROLS OVER AN INDIVIDUAL YEAR by N. A. Barbarash, N. I. Lazik, V. I. Shaposhnikova, M. V. Chichilenko, S. L. Barbarash, D. N. Kosyagin, O. L. Barbarash

Subjects: Get full text

Inflammation and Comorbidity. Are There any Chances to Improve the Prognosis in Patients with Extremely High Cardiovascular Risk? by M. V. Zykov, O. L. Barbarash

Subjects: Get full text

INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION by E. V. Tavlueva, A. V. Alekseenko, O. V. Gruzdeva, O. L. Barbarash

Get full text

LIPID CONTROL IN PATIENTS AFTER MYOCARDIAL INFARCTION - AN EFFECTIVE TOOL FOR MANAGING CARDIOVASCULAR RISKS by O. L. Barbarash, V. V. Kashtalap

“…The review article highlights the views reflected in the recent clinical guidelines related to high-intensity statin treatment and non statin cholesterol lowering drugs in patients with very high cardiovascular risk after myocardial infarction and the purpose of therapy. …”
Get full text

Stereotypes of eating behavior and risk factors for cardiovascular disease in residents of a large industrial region of Siberia by D. P. Tsygankova, E. D. Bazdyrev, E. V. Indukaeva, G. V. Artamonova, O. L. Barbarash

Subjects: Get full text

Features of plasminogen activator inhibitor-1 synthesis by local fat depots of different localization in cardiovascular diseases by E. V. Belik, O. V. Gruzdeva, Yu. A. Dyleva, E. E. Bychkova, A. A. Kuzmina, S. V. Ivanov, O. L. Barbarash

Get full text

Pre-diabetes as an interdisciplinary problem: definition, risks, approaches to the diagnostics and prevention of type 2 diabetes and cardiovascular complications by O. L. Barbarash, M. I. Voyevoda, G. R. Galstyan, M. V. Shestakova, S. A. Boytsov, O. Yu. Aleksandrova, S. M. Bryzgalina, I. V. Druk, V. N. Karetnikova, V. V. Kashtalap, L. V. Kvitkova, O. Yu. Korennova, M. Yu. Ogarkov, E. Yu. Plotnikova, O. V. Tsygankova, A. V. Svarovskaya, G. A. Chumakova

Subjects: Get full text

Register of patients with familial hypercholesterolemia and patients of very high cardiovascular risk with lipid-lowering therapy underperformance (RENESSANS) by M. V. Yezhov, S. A. Bliznyuk, N. A. Tmoyan, T. A. Rozhkova, D. V. Duplyakov, V. A. Salchenko, M. A. Kachkovsky, I. I. Shaposhnik, V. V. Genkel, V. S. Gurevich, S. А. Urazgildeeva, A. V. Tregubov, M. V. Muzalevskaya, S. S. Bazhan, O. V. Timoshchenko, I. A. Urvantseva, K. G. Kozhokar, A. A. Sokolov, V. V. Tishko, O. I. Boyeva, E. V. Bolotova, A. M. Namitokov, Yu. B. Kushnaryova, T. Yu. Kuznetsova, V. A. Korneva, D. Yu. Bogdanov, E. E. Chichina, V. M. Solovyov, A. I. Ershova, A. N. Meshkov, V. I. Makogonenko, A. S. Galyavich, D. I. Sadykova, B. V. Pomogaybo, O. L. Barbarash, V. V. Kashtalap, E. A. Shutemova, I. G. Isaeva, R. A. Khokhlov, V. E. Oleynikov, I. V. Avdeeva, V. V. Malakhov, U. V. Chubykina, V. O. Konstantinov, A. S. Aliyeva, V. V. Ovsyannikova, G. I. Furmenko, T. M. Chernykh, O. E. Abashina, A. R. Dzhanibekova, E. S. Slastnikova, L. F. Galimova, P. D. Duplyakova, M. I. Voyevoda

Subjects: Get full text

Impact of Pre-Diabetes on the Rate of Major Adverse Cardiovascular Events in Patients Undergoing Coronary Artery Bypass Grafting by A. N. Sumin, N. A. Bezdenezhnykh, A. V. Bezdenezhnykh, S. V. Ivanov, O. L. Barbarash

“…The prognosis was considered as unfavorable in case of any major adverse  cardiovascular events  (MACEs) defined as myocardial infarction, stroke,  cardiovascular death. …”
Get full text

Cardiovascular Comorbidity: Patient with Coronary Artery Disease and Peripheral Artery Atherosclerosis.... by O. L. Barbarash, V. V. Kashtalap, I. A. Shibanova

“…The positions of one of the components of cardiovascular comorbidity – multifocal atherosclerosis – are presented. …”
Get full text

THE ROLE OF C-REACTIVE PROTEIN AND POLYMORPHISMS OF ITS CANDIDATE GENES IN THE DEVELOPMENT OF IN-HOSPITAL CARDIOVASCULAR COMPLICATIONS IN PATIENTS AFTER CORONARY BYPASS SURGERY by O. L. Barbarash, Yu. V. Bayrakova, A. V. Ponasenko, S. V. Ivanov, Ya. V. Kazachek, M. V. Khutornaya, E. D. Bazdyrev, O. V. Gruzdeva, A. A. Kuzmina, L. S. Barbarash

Subjects: Get full text

Comparative evaluation of the expression of enzymes of the ceramide <i>de novo</i> synthesis pathway in cardiac adipose tissue and blood vessels of cardiovascular patients by O. V. Gruzdeva, Yu. A. Dyleva, E. V. Belik, E. G. Uchasova, A. V. Ponasenko, E. E. Gorbatovskaya, E. A. Fanaskova, S. V. Ivanov, A. N. Stasev, M. G. Zinets, O. L. Barbarash

Get full text